×

Loading...

这篇文章很有问题。政府宣传2针就够，测试人群也是2针居多，（2岁以下2针1166人，3针只有386人，退出只有10人，就是说2针数据是有的）。但为什么结论是3针有效而对市场上宣传的主流2针效率不提？

headbig(Let's Rock！)
A three-dose primary series of 3-μg BNT162b2 was safe, immunogenic, and efficacious in children 6 months to 4 years of age. (Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04816643.).
Full Story:
https://pubmed.ncbi.nlm.nih.gov/36791162/#&gid=article-figures&pid=figure-1-uid-0
(#15660159@0)
Last Updated: 2023-9-12
Sign in and Reply Report

Replies, comments and Discussions:

从辉瑞的儿童疫苗试验报告来看辉瑞和FDA的无耻
枫下论坛主坛 /  枫下家园 /  医药保健